Literature DB >> 10669154

The management of oral anticoagulant therapy: the patient's point of view.

D Barcellona1, P Contu, G G Sorano, V Pengo, F Marongiu.   

Abstract

The aims of this study were to investigate on the general adhesion of the patients to oral anticoagulant therapy, and particularly on the quality of life of our patients, the doctor-patient relationship and the Centre-patient relationship. For this purpose we administered a questionnaire containing 17 main questions each with a maximum of 4 secondary questions. The questionnaire was administered to two groups of 127 and 137 oral anticoagulated patients (127 males and 137 females, mean age 55 +/- 19 years), followed at two Anticoagulation Clinics, in two Italian cities, Cagliari (Sardinia) and Padua (North East Italy). The cities differed in the number of patients monitored and the management modalities of anticoagulation. The results show that oral anticoagulant therapy does not limit the life-style of the patients. Only 11% of the patients complain of limitations to their daily life. Fifty-two percent believe their health has improved, and 87% are not afraid of negative consequences. The doctor-patient relationship is considered very important by 96% of patients. Seventy-eight percent refer to the Anticoagulation Clinic also for other health problems, 93% consider it important to be assessed by the doctor at the Anticoagulation Clinic, while 83% believe the doctor should always hand out the results personally. We conclude that in general oral anticoagulant therapy is accepted by the majority of patients, in spite of the need for periodic monitoring. The doctor-patient relationship should be taken into account, even in the case of a monitored, computer-assisted method of dose-adjustment.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10669154

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  17 in total

Review 1.  Factors Affecting Patients' Perception On, and Adherence To, Anticoagulant Therapy: Anticipating the Role of Direct Oral Anticoagulants.

Authors:  Ekta Y Pandya; Beata Bajorek
Journal:  Patient       Date:  2017-04       Impact factor: 3.883

2.  A "two-step" educational approach for patients taking oral anticoagulants does not improve therapy control.

Authors:  Doris Barcellona; Paolo Contu; Francesco Marongiu
Journal:  J Thromb Thrombolysis       Date:  2006-12       Impact factor: 2.300

3.  Reorganisation of an anticoagulation clinic using a telemedicine system: description of the model and preliminary results.

Authors:  Sophie Testa; Adriano Alatri; Oriana Paoletti; Giampietro Morstabilini; Maria Anunzia Medagliani; Nadia Denti; Emanuela Martellenghi
Journal:  Intern Emerg Med       Date:  2006       Impact factor: 3.397

4.  Descriptive analysis of the process and quality of oral anticoagulation management in real-life practice in patients with chronic non-valvular atrial fibrillation: the international study of anticoagulation management (ISAM).

Authors:  Jack Ansell; Jennifer Hollowell; Vittorio Pengo; Fernando Martinez-Brotons; Jaime Caro; Ludovic Drouet
Journal:  J Thromb Thrombolysis       Date:  2007-04       Impact factor: 2.300

Review 5.  Patient values and preferences in decision making for antithrombotic therapy: a systematic review: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  Samantha MacLean; Sohail Mulla; Elie A Akl; Milosz Jankowski; Per Olav Vandvik; Shanil Ebrahim; Shelley McLeod; Neera Bhatnagar; Gordon H Guyatt
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

6.  What are the barriers to warfarin use in atrial fibrillation?: Development of a questionnaire.

Authors:  Anders Ingelgård; Jennifer Hollowell; Prabashni Reddy; Karen Gold; Kimbach Tran; David Fitzmaurice
Journal:  J Thromb Thrombolysis       Date:  2006-06       Impact factor: 2.300

7.  Concomitant drug, dietary, and lifestyle issues in patients with atrial fibrillation receiving anticoagulation therapy for stroke prophylaxis.

Authors:  Edith A Nutescu; Cathy M Helgason
Journal:  Curr Treat Options Cardiovasc Med       Date:  2005-07

8.  The criteria of the Italian Federation of Thrombosis Centres on DOACs: a "real world" application in nonvalvular atrial fibrillation patients already on vitamin K antagonist.

Authors:  Doris Barcellona; Miro Luzza; Nicola Battino; Lara Fenu; Francesco Marongiu
Journal:  Intern Emerg Med       Date:  2014-12-09       Impact factor: 3.397

Review 9.  Thyroid, hemostasis and thrombosis.

Authors:  F Marongiu; C Cauli; S Mariotti
Journal:  J Endocrinol Invest       Date:  2004-12       Impact factor: 4.256

10.  Multinational development of a questionnaire assessing patient satisfaction with anticoagulant treatment: the 'Perception of Anticoagulant Treatment Questionnaire' (PACT-Q).

Authors:  Martin H Prins; Alexia Marrel; Paulo Carita; David Anderson; Marie-Germaine Bousser; Harry Crijns; Silla Consoli; Benoit Arnould
Journal:  Health Qual Life Outcomes       Date:  2009-02-06       Impact factor: 3.186

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.